Skaana Management’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Skaana Management’s Portfolio GRNAW Stock Details GRNAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$0	Hold	5,000	–	–	﹤0.01%	191
2025 Q4	$0	Hold	5,000	–	–	﹤0.01%	188
2025 Q3	$0	Hold	5,000	–	–	﹤0.01%	176
2025 Q2	$0	Hold	5,000	–	–	﹤0.01%	167
2025 Q1	$0	Hold	5,000	–	–	﹤0.01%	184
2024 Q4	$0	Hold	5,000	–	–	﹤0.01%	185
2024 Q3	$0	Hold	5,000	–	–	﹤0.01%	177
2024 Q2	$0	Hold	5,000	–	–	﹤0.01%	196
2024 Q1	$0	Hold	5,000	–	–	﹤0.01%	227
2023 Q4	$0	Hold	5,000	–	–	﹤0.01%	221
2023 Q3	$0	Buy	+5,000	New	+$73	﹤0.01%	228

Skaana Management's GRNAW Position: Q1 2026 in Review

Skaana Management held its GreenLight Biosciences Holdings, PBC Warrant (GRNAW) position steady in Q1 2026 at 5,000 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #191.

Skaana Management first reported a position in GRNAW in Q3 2023 and has held it in 11 quarters since. 1 fund tracked by Wall St. Rank holds GRNAW as of Q1 2026.

Skaana Management held 5,000 shares of GreenLight Biosciences Holdings, PBC Warrant worth $0 as of Q1 2026.
Skaana Management left its GreenLight Biosciences Holdings, PBC Warrant share count unchanged in Q1 2026.
GreenLight Biosciences Holdings, PBC Warrant made up ﹤0.01% of Skaana Management's portfolio in Q1 2026, its #191 holding.
Skaana Management first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q3 2023 and has held it in 11 quarters since.
1 fund tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q1 2026.

Based on Skaana Management's 13F filing for Q1 2026, filed 11 May 2026.